Search – Page 135 – Indianapolis Business Journal

Home » Search

Articles

The Interview Issue: Dave Ricks

September 22, 2016 | John Russell

On Jan. 1, Dave Ricks becomes CEO of drugmaker Eli Lilly and Co. as it tries to launch new products after a tough stretch of patent expirations. To prepare, Ricks has spent a lot of time with outgoing CEO John Lechleiter “learning from the master.”

The Interview Issue: Jim Shella

September 22, 2016

WISH-TV political reporter Jim Shella has spent 40 years in the news business—most of it at the Indiana Statehouse—and 25 years as host of “Indiana Week in Review” on WFYI.

Drugmaker Pfizer decides not to break up business

September 26, 2016

The rival and sometimes-partner for Indianapolis-based Eli Lilly and Co. will not split into two publicly traded companies, it said Monday.

Priority list includes old Hoosier gyms, new choreography, more

September 26, 2016

The week also includes appearances by pianist Lang Lang and comedian Hannibal Buress.

BART PETERSON: Embracing the ‘connectivity economy’

September 29, 2016

To succeed in the 21st century, we need easy access—and we need to be easily accessible to—markets, ideas, capital and talent from coast to coast and around the world. Those are the four elements of the new connectivity economy.

Analysis: Diabetes drug price war likely to claim more casualties

September 30, 2016

Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.

Americans getting fed up over high drug prices

October 3, 2016

A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.

Indiana Biosciences Research Institute picks chief scientific officer

October 5, 2016

Rainer Fischer most recently served as senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany. The institute is part of the largest applied science research organization in Europe.

Lilly’s Elanco unit buying pet-vaccine portfolio for $885M

October 5, 2016

The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.

Wall Street analysts jumping on Lilly train

October 6, 2016

For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.

MORRIS: Zoo prize finalists are inspiration

October 13, 2016

This conservation effort and the zoo that sponsors it deserve your support.

URBAN DESIGN: Time to imagine a High Line for Indianapolis

October 13, 2016

City should take bold step of creating an elevated park on downtown rail corridor.

Princeton to pay $18 million to settle residents’ tax case

October 17, 2016

The residents who sued sought to revoke the school’s property-tax exemption, in part because Princeton shares commercial royalties with faculty from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.

Lilly pledges $90 million to improve global drug access

October 18, 2016

Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.

« Previous 1 … 133 134 135 136 137 … 221 Next »

Search Results

4,411 results for '\"eli lilly\"'